Search results
Author(s):
Christopher R deFilippi
,
G Michael Felker
Added:
3 years ago
Biomarkers have become central to the management of cardiovascular disease, and their potential clinical applications continue to grow. This article reviews galectin-3 (Gal-3), a novel biomarker of fibrosis and remodeling, and its clinical application in heart failure (HF).
Case Studies
Case Study One
A 63-year-old African-American female presents to the emergency department with acute dyspnea…
View more
Author(s):
Felix Mahfoud
Added:
2 years ago
In this video, Dr Felix Mahfoud (Saarland University Hospital, Hamburg, DE) discusses the use of the Win Ratio Methodology when applied to the Global SYMPLICITY Study. This registry consisted of the largest followed population of real-world patients with hypertension treated with renal denervation.
Questions:
What is the rationale behind this study?
What is the design, patient cohort and…
View more
Homocysteine-lowering Treatment in Reduction of Stroke and Coronary Vascular Risk - Do Not Give Up
Author(s):
Wolfgang Herrmann
,
Rima Obeid
Added:
3 years ago
Article
Author(s):
Harriette Van Spall
,
Dike Bevis Ojji
Added:
4 months ago
AHA 2023 — Investigator Dr Dike Bevis Ojji (University of Abuja, NG) talks with Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) about the Hypertension Treatment in Nigeria Program (NCT04158154).The aim of this study (Washington University School of Medicine) and employing an interrupted time series design, is to assess the implementation and evaluation of a culturally- and…
View more
Author(s):
Philip J Devereaux
Added:
1 year ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Philip J Devereaux (McMaster University, ON, CA) discusses the POISE-3 trial which was a large international, non-inferiority randomised controlled trial evaluating the efficacy and safety of tranexamic acid (TXA) versus placebo for controlling perioperative bleeding in the noncardiac surgical setting (NCT03505723).
…
View more
Author(s):
Paul A Friedman
,
Stephen C Hammill
Added:
3 years ago
Atrial fibrillation (AF) is a rhythm disturbance of the atria that results in irregular, chaotic, ventricular waveforms, varying from bradyarrhythmia to tachyarrhythmia. Essentially, all forms of AF therapy can be divided into two categories - restoration and maintenance of normal sinus rhythm, or control of the ventricular rate while permitting on-going fibrillation of the atria. Although…
View more
Chest Pain in Women
Author(s):
Mariem A Sawan
,
Rebecca S Steinberg
,
Michael N Sayegh
,
et al
Added:
4 months ago
Article
Author(s):
Suneet Mittal
,
Jonathan S Steinberg
,
Andrew Choi
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The prevalence of AF increases with age;1 one and approximately 2.3 million US adults are currently afflicted with AF, with that number projected to increase to 5.6 million by the year 2050.2
AF typically results in an irregular rhythm with poorly controlled ventricular rate and loss of atrial…
View more
Author(s):
Harold Djodjo Kano
,
Wei Sun
Added:
5 months ago
The Implantable Loop Recorder
Author(s):
Richard Sutton
,
Michele Brignole
Added:
3 years ago
Article